Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-013751

Options or other derivatives

  • Chief Executive Officer acquired 142,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Schenkein David P Chief Executive Officer 2017-02-21 Grant or award · Stock option (right to buy) +142,900 142,900 D
Loading xslF345X03/doc4.xml…